Arkolith/Insider Trading/ANAB/Form 4/A

Faga Daniel

President, CEO, DirectorANAPTYSBIO, INC (ANAB) · full profile →Form 4/A · filed Apr 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2026Disposed to issuer(D)11K—$011K

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001673528-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML